SCI REP-UK:幸福感较高的国家中,有压力的人拥有的幸福更少

2022-02-22 K.K MedSci原创

他人将积极情绪的体验作为生活中成功的关键展示出来,这可能对自我感到幸福有着消极的影响。

2月17日,发表在《科学报告》上的研究发现,在国民幸福感较高的国家,有社会压力的人比幸福感较低的国家人拥有的幸福感更少。

 

Egon Dejonckheere, Perceiving societal pressure to be happy is linked to poor well-being, especially in happy nations, Scientific Reports (2022). DOI: 10.1038/s41598-021-04262-z.

研究人员对来自40个国家的7443人进行了调查,了解他们的情绪健康、对生活的满意度和情绪,并要求每个人谈谈他们对社会期望感到积极的看法。

被评为具有较高幸福感的国家包括荷兰和加拿大,被评为较低幸福感的国家包括乌干达和塞内加尔。在这项研究的样本中,几乎所有国家都报告了社会压力,且与幸福感差有关,但国家之间存在着差异。

即使在幸福感水平较高的国家,个人感到有压力也与幸福感差有关。在世界幸福指数(WHI)得分较高的国家,社会压力与槽糕福利之间的关系几乎是幸福得分较低的国家的两倍。作者总结说,国家的幸福指数高并不表示这个国家的每个人都有较高的幸福感。糟糕的福利包括生活满意度下降、更少和更不强烈的积极情绪以及更多的抑郁、焦虑和压力。主要作者Egon Dejonckheere说,"自我感到压力还想要达到幸福可能是无法实现的。”

 

各国WHI得分与参与者感知到的社会压力之间的互动关系

研究人员还揭示了个人的情感生活和社会认可之间的差异。个人和社会之间产生差异可能会引发失败感,从而导致负面情绪。

在许多国家,感觉到社会压力实际上与积极的幸福感无关,甚至在少数国家,出现了相反的关联。而社会对幸福的溢价、更高的生活满意度和强烈的积极情绪体验有关,人们感受到压力与更多、更强烈的负面情绪、抑郁、焦虑症状有关。

在较幸福的国家中,他人将积极情绪的体验作为生活中成功的关键展示出来,这可能对自我感到幸福有着消极的影响。

参考资料:

Egon Dejonckheere, Perceiving societal pressure to be happy is linked to poor well-being, especially in happy nations, Scientific Reports (2022). DOI: 10.1038/s41598-021-04262-z.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-03-04 cycy_20070101

    了解一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-24 130a765fm69暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-24 乐佳佳

    ...

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-24 1351fc2f66m

    看看新理念

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-23 ms1000001191450835

    。。。。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-23 387753

    sci rep和科学没啥关系

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1199375, encodeId=4df311993e5ae, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210417/3a1f62c4b21f41f6b9426333fccc56aa/6226cf86bdc74e88b06d022cb497c4c5.jpg, createdBy=e64d1346222, createdName=cycy_20070101, createdTime=Fri Mar 04 13:56:13 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197051, encodeId=3f9b119e0516a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Thu Feb 24 23:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196781, encodeId=a7141196e8167, content=..., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55452104431, createdName=乐佳佳, createdTime=Thu Feb 24 12:00:19 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196653, encodeId=155d1196653c0, content=看看新理念, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Thu Feb 24 02:59:17 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196464, encodeId=2c041196464d9, content=。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Wed Feb 23 16:47:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196377, encodeId=d0dd11963e78d, content=sci rep和科学没啥关系, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cc11369042, createdName=387753, createdTime=Wed Feb 23 11:54:43 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196203, encodeId=8e7d119620311, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Tue Feb 22 20:06:19 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196192, encodeId=c32011961929c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Tue Feb 22 20:00:41 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-22 ms8000002000106074

    学习

    0

相关资讯

用神药的代价是阿尔兹海默症风险升高50%?二甲双胍再遭滑铁卢!

Sci Rep.:二甲双胍与新诊断的2型糖尿病患者阿尔茨海默病的相关性:一项基于人群的巢式病例对照研究

一次满足3个愿望!这项国粹让心脏病人也能安全锻炼身心、提高生活质量!

BMC Complement Med Ther.:太极能改善心血管疾病和/或心血管危险因素患者的心理健康和生活质量吗?系统回顾

肠胃不好emo了?老祖宗出手不用愁!针灸能有效缓解功能性胃肠道疾病患者情绪症状!

PLOS ONE:针灸治疗功能性胃肠道疾病患者的情绪症状:系统评价和荟萃分析

该引起重视了!减压、不熬夜写入科学声明

近日,美国心脏协会(AHA)发表了科学建议,指出健康生活方式的五个维度是健康饮食、规律活动、远离烟草、不熬夜(adequate sleep)和减轻压力(managing stress)。

研究显示,休息日处理工作,会对身心健康产生重大影响

在家中不断等待工作通知会影响新陈代谢和免疫力,使人更容易受到感染、高血压和抑郁等严重健康问题的影响。

Diabetes Care:COVID-19期间2型糖尿病老年人抑郁、孤独和失眠患病率变化情况

在COVID-19期间,老年糖尿病患者轻度或中度抑郁症状的患病率是COVID-19大流行之前的1.6倍以上。